132 related articles for article (PubMed ID: 8504397)
1. Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes.
de Vries JE; Kornips FH; Marx P; Bosman FT; Geraedts JP; ten Kate J
Cancer Genet Cytogenet; 1993 May; 67(1):35-43. PubMed ID: 8504397
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal rearrangements involving telomeric DNA sequences in Balb/3T3 cells transfected with the Ha-ras oncogene.
Peitl P; Mello SS; Camparoto ML; Passos GA; Hande MP; Cardoso RS; Sakamoto-Hojo ET
Mutagenesis; 2002 Jan; 17(1):67-72. PubMed ID: 11752236
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal localization of transfected genes by a combination of hot banding and fluorescence in situ hybridization.
De Vries JE; Kornips FH; Wiegant J; Moerkerk PM; Senden N; Schutte B; Geraedts JP; Bosman FT; Ten Kate J
J Histochem Cytochem; 1992 Jul; 40(7):1053-8. PubMed ID: 1607638
[TBL] [Abstract][Full Text] [Related]
4. c-Ha-ras oncogene transfection does not affect NK cell sensitivity of human colorectal carcinoma cell lines.
van Ierssel GJ; de Vries JE; Mierement-Ooms MA; van der Zon AM; ten Kate J; Lamers CB; Verspaget HW
Anticancer Res; 1995; 15(2):349-52. PubMed ID: 7763005
[TBL] [Abstract][Full Text] [Related]
5. Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras.
Denko N; Stringer J; Wani M; Stambrook P
Somat Cell Mol Genet; 1995 Jul; 21(4):241-53. PubMed ID: 8525430
[TBL] [Abstract][Full Text] [Related]
6. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites.
Rassool FV; McKeithan TW; Neilly ME; van Melle E; Espinosa R; Le Beau MM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6657-61. PubMed ID: 1862089
[TBL] [Abstract][Full Text] [Related]
7. Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA.
Rassool FV; Le Beau MM; Neilly ME; van Melle E; Espinosa R; McKeithan TW
Am J Hum Genet; 1992 Jun; 50(6):1243-51. PubMed ID: 1317992
[TBL] [Abstract][Full Text] [Related]
8. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection.
Ichikawa T; Kyprianou N; Isaacs JT
Cancer Res; 1990 Oct; 50(19):6349-57. PubMed ID: 2119253
[TBL] [Abstract][Full Text] [Related]
9. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
[TBL] [Abstract][Full Text] [Related]
10. Neoplastic transformation of a human kidney epithelial cell line transfected with v-Ha-ras oncogene.
Haugen A; Ryberg D; Hansteen IL; Amstad P
Int J Cancer; 1990 Mar; 45(3):572-7. PubMed ID: 2407668
[TBL] [Abstract][Full Text] [Related]
11. [Integration of DNA oscillatory vector pSV neo to genome of NIH3T3: importance in investigations of transformation with c-Ha-ras oncogene].
Burzyński A; Wiśniewski R; Wojciechowski W; Porwit-Bóbr Z
Med Dosw Mikrobiol; 1994; 46(1-2):35-41. PubMed ID: 7967925
[TBL] [Abstract][Full Text] [Related]
12. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.
Denko NC; Giaccia AJ; Stringer JR; Stambrook PJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):5124-8. PubMed ID: 8197195
[TBL] [Abstract][Full Text] [Related]
13. The influence of interstitial telomeric sequences on chromosome instability in human cells.
Desmaze C; Alberti C; Martins L; Pottier G; Sprung CN; Murnane JP; Sabatier L
Cytogenet Cell Genet; 1999; 86(3-4):288-95. PubMed ID: 10575228
[TBL] [Abstract][Full Text] [Related]
14. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line.
Matzner I; Savelyeva L; Schwab M
Cancer Lett; 2003 Jan; 189(2):207-19. PubMed ID: 12490314
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells.
Testa JE; Medcalf RL; Cajot JF; Schleuning WD; Sordat B
Int J Cancer; 1989 May; 43(5):816-22. PubMed ID: 2497073
[TBL] [Abstract][Full Text] [Related]
16. The transient expression of mRNA coding for Rep protein from AAV facilitates targeted plasmid integration.
Howden SE; Voullaire L; Vadolas J
J Gene Med; 2008 Jan; 10(1):42-50. PubMed ID: 18001001
[TBL] [Abstract][Full Text] [Related]
17. The activated human c-Ha-ras-1 oncogene as a mutagen.
Baron HM; Bobrisheva IV; Varshaver NB
Cancer Genet Cytogenet; 1992 Aug; 62(1):15-20. PubMed ID: 1521228
[TBL] [Abstract][Full Text] [Related]
18. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
[TBL] [Abstract][Full Text] [Related]
19. Detection of oncogene mRNA sequences in cultured cells by in situ hybridization.
Stoner GD; You M; Skouv J; Budd GC; Pansky B; Wang Y
Ann Clin Lab Sci; 1987; 17(2):74-82. PubMed ID: 3579212
[TBL] [Abstract][Full Text] [Related]
20. Gene targeting approach to selectively kill colon cancer cells, with hyperactive K-Ras pathway.
Dvory-Sobol H; Kazanov D; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S370-4. PubMed ID: 16507412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
